BiotechEast - Taiwan and China biotechnology, medical devices, pharmaceuticals, ^¤å½s×, ^¤å×§ï ::

Article Search:

BiotechEast

· Home
· About us
· Services
· FAQ
· Contact us

Info Resources

· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out

Partners

Previous 5 6 7 8 9 10 11 12 13 14 ... Total pages:219 Next

(Taiwan) Taiwanese scientist makes breakthrough in biotracer research

(Focus Taiwan News Channel)

16 April, 2010
A Taiwan-trained biomedical engineer has gained international renown with a breakthrough in creating a new generation of biotracer, the National Science Council (NSC) said Friday.
More...

(Taiwan) Medinox and Orient Europharma Announce Collaboration on Developing NOX-100, a New Anti-Hypotensive Drug

(prnewswire.com)

12 April, 2010
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
More...

(Taiwan) Cancer drugs the top sellers in Taiwan: report

(Focus Taiwan New Channel)

27 March, 2010
Drugs for the treatment of cancer, high cholesterol, hypertension and diabetes were the top-selling medicines in Taiwan last year, according to a report by IMS Health, a U.S-based pharmaceutical data management company.
More...

(Taiwan) Taiwan scientist unveils rapid, low-cost TB test kit

(AFP)

28 March, 2010
A Taiwan scientist on Sunday unveiled what he said is the first low-cost and efficient test kit for identifying tuberculosis bacteria, killer of more than 1.5 million people worldwide every year.
More...

(Taiwan) TaiGen announces Nemonoxacin (TG-873870) once-a-day oral dosing in diabetic foot infection met primary endpoints

(Press release, TaiGen Biotechnology Co., Ltd.)

21 March, 2010
TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability.

(Taiwan) PharmaEssentia announces commencement of Phase I clinical trial for its HBV/HCV drug candidate P1101 (PEG-P-IFN-alpha)

(Press release, PharmaEssentia Corp.)

11 December, 2009

Taipei, Taiwan-based biopharmaceutical company PharmaEssentia Corp. today announced the initiation of a Phase I clinical trial for its innovative PEG chemistry rationale-designed hepatitis B and C drug candidate P1101 (PEG-P-IFN-alpha).

(Taiwan) ScinoPharm announces SafeBridge Potent Compound Safety Certification

(BiotechEast staff)

30 November, 2009
ScinoPharm, an active pharmaceutical ingredients (APIs) manufacturer based in Taiwan announced recently that its Tainan facility had received 'Potent Compound Safety Certification' from SafeBridge Consultants, Inc., a US-based consulting firm servicing the pharmaceutical industries.

(Taiwan) Innovation and excellence honored at awards event: Formosa Laboratories wins top prize, GaleMed comes in second, InnoPharmax takes third

(Press release, Epoch Foundation)

20 November, 2009
The "Taiwan Healthcare Industry Innovation and Excellence Awards 2009," recognizing achievements in the local life sciences sector, was held yesterday at a ceremony at Taipei's Grand Hyatt Hotel.

(China) ScinoPharm breaks ground at new manufacturing facility in China

15 November, 2009
ScinoPharm Taiwan Ltd., a global supplier of active pharmaceutical ingredients (APIs), has started construction of a new plant on a 66670 square meter site in Changshu, Jiangsu province in China.

(Taiwan) Medical device firm SHL receives quality recognition award from Amgen

(BiotechEast staff)

22 October, 2009
Staff at SHL, a manufacturer of drug delivery devices, gathered at the company's Taoyuan, Taiwan-headquarters Wednesday to receive an award recognizing operational excellence from Amgen, the world's largest biotechnology company and a long-time customer of SHL's auto injector products.

Events